Article
Biochemical and metabolic maladaption defines pathological niches in progressive multiple sclerosis
2022-09-27
Abstract excerpt
Progressive multiple sclerosis (MS) is driven by demyelination, neuroaxonal loss, and mitochondrial damage occurring behind a closed blood-brain barrier (BBB). 1,2 Patients with progressive MS typically fail to respond to available immunomodulatory drugs that reduce relapses in early disease. 2 This indicates a dire need to identify non-canonical therapeutic avenues to limit neurodegeneration and promote protect...
Topics
Open a Topic to create a Post that cites this publication.
- Bone and Dental Protein Studies
- Cell Adhesion Molecules Research
- Cellular Mechanics and Interactions
- Multiple Sclerosis Research Studies
- Neurogenesis and neuroplasticity mechanisms
- Neuroinflammation and Neurodegeneration Mechanisms
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Single-cell and spatial transcriptomics
Identifiers and source
- Literature Corpus work
- 60cb3974-97b3-58e7-8b8e-bd4fda57fc08
- DOI
- 10.1101/2022.09.26.509462
